Bausch Lomb Ireland Drug Patent Portfolio
Bausch Lomb Ireland owns 2 orange book drugs protected by 7 US patents Given below is the list of Bausch Lomb Ireland's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10293047 | Fluorescein and benoxinate compositions | 15 Nov, 2037 | Active |
| US10632197 | Fluorescein and benoxinate compositions | 15 Nov, 2037 | Active |
| US10842872 | Fluorescein and benoxinate compositions | 15 Nov, 2037 | Active |
| US5756541 | Vision through photodynamic therapy of the eye | 11 Mar, 2016 | Expired |
| US5798349 | Use of green porphyrins to treat neovasculature in the eye | 25 Aug, 2015 | Expired |
| US5707608 | Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer | 02 Aug, 2015 | Expired |
| US5770619 | Method of activating photosensitive agents | 06 Jan, 2015 | Expired |
Latest Legal Activities on Bausch Lomb Ireland's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Bausch Lomb Ireland.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 19 Apr, 2024 | US10842872 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 20 Sep, 2023 | US10632197 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Jan, 2023 | US10293047 |
| Surcharge for Late Payment, Large Entity | 17 Jan, 2023 | US10293047 |
|
Maintenance Fee Reminder Mailed
Critical
| 09 Jan, 2023 | US10293047 |
|
Recordation of Patent Grant Mailed
Critical
| 24 Nov, 2020 | US10842872 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Nov, 2020 | US10842872 |
|
Email Notification
Critical
| 05 Nov, 2020 | US10842872 |
|
Issue Notification Mailed
Critical
| 04 Nov, 2020 | US10842872 |
| Dispatch to FDC | 27 Oct, 2020 | US10842872 |
|
Application Is Considered Ready for Issue
Critical
| 26 Oct, 2020 | US10842872 |
|
Issue Fee Payment Received
Critical
| 23 Oct, 2020 | US10842872 |
|
Issue Fee Payment Verified
Critical
| 23 Oct, 2020 | US10842872 |
|
Email Notification
Critical
| 11 Sep, 2020 | US10842872 |
|
PG-Pub Issue Notification
Critical
| 10 Sep, 2020 | US10842872 |
Bausch Lomb Ireland's Family Patents
Bausch Lomb Ireland Drug List
Given below is the complete list of Bausch Lomb Ireland's drugs and the patents protecting them.
1. Fluorescein Sodium And Benoxinate Hydrochloride
Fluorescein Sodium And Benoxinate Hydrochloride is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10293047 | Fluorescein and benoxinate compositions |
15 Nov, 2037
(13 years from now)
| Active |
| US10632197 | Fluorescein and benoxinate compositions |
15 Nov, 2037
(13 years from now)
| Active |
| US10842872 | Fluorescein and benoxinate compositions |
15 Nov, 2037
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fluorescein Sodium And Benoxinate Hydrochloride's drug page
2. Visudyne
Visudyne is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5756541 | Vision through photodynamic therapy of the eye |
11 Mar, 2016
(8 years ago)
| Expired |
| US5798349 | Use of green porphyrins to treat neovasculature in the eye |
25 Aug, 2015
(9 years ago)
| Expired |
| US5707608 | Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer |
02 Aug, 2015
(9 years ago)
| Expired |
| US5770619 | Method of activating photosensitive agents |
06 Jan, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Visudyne's drug page